Thrombosis Management in Developing Countries

Thrombosis, encompassing conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE), is a global health concern with significant implications for morbidity and mortality. While thrombosis management has made notable strides worldwide, developing countries face unique challenges in addressing this complex medical issue. This chapter discusses the prevalence, morbidity, and mortality of thrombosis in developing countries, explores the clinical, economic, and humanistic burdens, and provides recommendations for improving thrombosis management in these regions. Prevalence studies reveal that thrombosis is not limited to developed nations, with developing countries witnessing an increasing burden due to shifting demographics, lifestyle changes, and the rising incidence of risk factors like obesity and diabetes. This escalating prevalence is associated with significant morbidity, including chronic complications, disabilities, and reduced quality of life, imposing a substantial economic burden on healthcare systems and patients. Moreover, thrombosis-related mortality remains a challenge, exacerbated by delayed diagnosis, limited access to specialized care, and disparities in healthcare delivery. Addressing these challenges necessitates a multifaceted approach. Recommendations include expanding public awareness and education, strengthening healthcare infrastructure, adapting international guidelines to local contexts, promoting telemedicine, ensuring medication accessibility, and fostering collaboration between stakeholders. These strategies aim to improve thrombosis prevention, diagnosis, treatment, and patient education in developing countries. Efforts to enhance thrombosis management in these regions are part of the broader global health agenda, striving for equitable healthcare access and reduced health disparities. These recommendations acknowledge the unique needs and limitations of developing countries, emphasizing adaptability and collaboration to achieve effective outcomes. Furthermore, continuous research, data collection, and evaluation are essential to measure the impact of interventions and refine approaches over time. In conclusion, addressing thrombosis in developing countries is a vital global health imperative. With concerted efforts from governments, healthcare organizations, NGOs, international partners, and the private sector, developing countries can significantly improve thrombosis care, reduce its impact on populations, and contribute to improved health and well-being for all.